Delivery Order SPE2DB20D2104-SPE2DB25FMYUK
- Not listed
- The Defense Logistics Agency awarded a $2,052.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lokelma 10 gram powder packets (quantity 30) on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a non-set-aside contract awarded through open competition. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends...
- The Defense Logistics Agency awarded a $42,545.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lokelma 10-gram powder packets (30-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside contract is to be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $1,544.50 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Lokelma 10 gram powder packets (30-count unit). This is a firm fixed price, non-set-aside contract with performance completion targeted for August 28, 2025, and fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,638.62 to AmerisourceBergen Drug Corp for Lokelma 10 gram powder packets (30-count package). This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price pharmaceutical supply under the company's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,003.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lokelma 5 gram powder packets (30-count package) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-competitive, non-set-aside award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,617.94 to AmerisourceBergen Drug Corp for Lokelma 10 gram powder packets (30-count supply) on March 4, 2025, with an ultimate completion date of March 5, 2025. This competitively awarded, firm fixed-price contract was executed without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lokelma is a potassium-binding medication used to treat hyperkalemia, a condition commonly...
- The Defense Logistics Agency awarded a $1,548.63 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lokelma 10 gram powder packets (30-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of August 1, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- This is a $6,326.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOKELMA 5 gram powder packets, which are used to treat hyperkalemia. The contract has an ultimate completion date of April 10, 2023 and was awarded on April 9, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order for Lokelma 10 gram powder packets awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,608.38 firm fixed-price contract has a completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lokelma, a 5-gram powder packet medication, in quantities of 30. The contract has a ceiling value of $10,895.58 and is a firm fixed-price delivery order, with a final completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYUKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,597.86 on August 25, 2025, for the supply of Lokelma 10 gram powder packets (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. Lokelma (sodium zirconium cyclosilicate) is a potassium-binding agent used to treat hyperkalemia, a condition relevant to military and veteran healthcare needs. The company's extensive federal contract portfolio demonstrates its capability to fulfill federal medical procurement requirements through open competition, with delivery orders ranging from small transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/25/25 |